A kampo medicine, Yin-Chiao-san, prevents bleomycin-induced pulmonary injury in rats

Phytotherapy Research

Volumn 21, Issue 3, 2007, Pages 251-258

  Yen, Feng Lin ^a   Wu, Tzu Hui ^a   Liao, Chia Wen ^a   Lin, Chun Ching ^a  

^a KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Antioxidant; Bleomycin; Hydroxyproline; Pulmonary fibrosis; Yin Chiao San

Indexed keywords

ALPHA TOCOPHEROL; BLEOMYCIN; CATALASE; CHINESE DRUG; COLLAGEN; HYDROXYPROLINE; MALONALDEHYDE; PLANT EXTRACT; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; YIN CHIAO SAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; CANCER CHEMOTHERAPY; CHINESE MEDICINE; COLLAGEN SYNTHESIS; CONTROLLED STUDY; EXPERIMENTAL MODEL; HISTOPATHOLOGY; LUNG FIBROSIS; LUNG INJURY; MALE; NONHUMAN; RAT; SEVERE ACUTE RESPIRATORY SYNDROME;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTIOXIDANTS; BLEOMYCIN; BRONCHOALVEOLAR LAVAGE FLUID; DRUGS, CHINESE HERBAL; FREE RADICAL SCAVENGERS; LUNG; MALE; MEDICINE, KAMPO; PHYTOTHERAPY; PLANTS, MEDICINAL; PULMONARY FIBROSIS; RATS; RATS, WISTAR; SPECIFIC PATHOGEN-FREE ORGANISMS;

ANIMALIA; RATTUS;

EID: 33947606381     PISSN: 0951418X     EISSN: 10991573     Source Type: Journal    
DOI: 10.1002/ptr.2056     Document Type: Article

References (34)

1. Arslan SO, Zerin M, Vural H, Coskun A. 2002. The effect of melatonin on bleomycin-induced pulmonary fibrosis in rats. J Pineal Res 32: 21-25.
2. Beinert T, Binder D, Stuschke M et al. 1999. Oxidant-induced lung injury in anticancer therapy. Eur J Med Res 4: 43-53.
3. Boismenu D, Lepine F, Gagnon M, Dugas H. 1989. Catalase activity measurement with the disk flotation method. Anal Biochem 178: 404-407.
4. Bowler RP, Nicks M, Warnick K, Crapo JD. 2002. Role of extracellular superoxide dismutase in bleomycin-induced pulmonary fibrosis. Am J Physiol Lung Cell Mol Physiol 282: 719-726.
5. Chang WS, Chang YH, Lu FJ, Chiang HC. 1994. Inhibitory effects of phenolics on xanthine oxidase. Anticancer Res 14: 501-506.
6. Coker RK, Laurent GJ. 1998. Pulmonary fibrosis: cytokines in the balance. Eur Respir J 11: 1218-1221.
7. Conklin KA. 2000. Dietary antioxidants during cancer chemotherapy: impact on chemotherapeutic effectiveness and development of side effects. Nutr Cancer 37: 1-18.
8. El-Medany A, Hagar HH, Moursi M, Muhammed R, El-Rakhawy FI, El-Medany G. 2005. Attenuation of bleomycin-induced lung fibrosis in rats by mesna. Eur J Pharmacol 509: 61-70.
9. Gurujeyalakshmi G, Wang Y, Giri SN. 2000. Suppression of bleomycin-induced nitric oxide production in mice by taurine and niacin. Nitric Oxide 4: 399-411.
10. Jules-Elysee K, White DA. 1990. Bleomycin-induced pulmonary toxicity. Clin Chest Med 11: 1-20.
11. Kang OH, Choi YA, Park HJ et al. 2004. Inhibition of trypsin-induced mast cell activation by water fraction of Loniera japonica. Arch Pharm Res 27: 1141-1146.
12. Kim JA, Kim DK, Kang OH et al. 2005. Inhibitory effect of luteolin on TNF-alpha-induced IL-8 production in human colon epithelial cells. Int Immunopharmacol 5: 209-217.
13. Kohno M, Yamada M, Mitsuta K, Mizuta Y, Yoshikawa T. 1991. Spin-trapping studies on the reaction of iron complex with peroxides and the effect of water-soluble antioxidants. Bull Chem Soc Jpn 64: 1447-1453.
14. Kuroki M, Noguchi Y, Shimano M et al. 2003. Repression of bleomycin-induced pneumopathy by TNF. J Immunol 170: 567-574.
15. Laughton MJ, Halliwell B, Evans PJ, Hoult JR. 1989. Antioxidant and pro-oxidant actions of the plant phenolics quercetin, gossypol and myricetin. Effects on lipid peroxidation, hydroxyl radical generation and bleomycin-dependent damage to DNA. Biochem Pharmacol 38: 2859-2865.
16. Lin CC, Yen FL, Hsu FF, Lin JM. 2000. Anti-hypercholesterolaemia, antioxidant activity and free radical scavenger effects of traditional Chinese medicine prescriptions used for stroke. J Pharm Pharmacol 52: 1387-1393.
17. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. 1951. Protein measurement with the Folin phenol reagent. J Biol Chem 193: 265-275.
18. McCord JM, Fridovich I. 1969. Superoxide dismutase. Anenzymic function for erythrocuprein (hemocuprein). J Biol Chem 244: 6049-6055.
19. Maeda A, Ishioka S, Taooka Y, Hiyama K, Yamakido M. 1999. Expression of transforming growth factor-beta1 and tumour necrosis factor-alpha in bronchoalveolar lavage cells in murine pulmonary fibrosis after intraperitoneal administration of bleomycin. Respirology 4: 359-363.
20. Manoury B, Nenan S, Leclerc O et al. 2005. The absence of reactive oxygen species production protects mice against bleomycin-induced pulmonary fibrosis. Respir Res 6: 1-12.
21. Mitsuta K, Mizuta Y, Kohno M, Hiramatsu M, Mori A. 1990. The application of ESR spin-trapping technique to the evaluation of SOD-like activity of biological substances. Bull Chem Soc Jpn 63: 187-191.
22. Ohkawa H, Ohishi N, Yagi K. 1979. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 95: 351-358.
23. Prieto JM, Recio MC, Giner RM, Manez S, Giner-Larza EM, Rios JL. 2003. Influence of traditional Chinese anti-inflammatory medicinal plants on leukocyte and platelet functions. J Pharm Pharmacol 55: 1275-1282.
24. Riley DJ, Berg RA, Edelman NH, Prockop DJ. 1980. Prevention of collagen deposition following pulmonary oxygen toxicity in the rat by cis-4-hydroxy-L-proline. J Clin Invest 65: 643-651.
25. Schinella GR, Tournier HA, Prieto JM, Mordujovich de Buschiazzo P, Rios JL. 2002. Antioxidant activity of anti-inflammatory plant extracts. Life Sci 70: 1023-1033.
26. Smith RE, Strieter RM, Phan SH, Lukacs N, Kunkel SL. 1998. TNF and IL-6 mediate MIP-1alpha expression in bleomycin-induced lung injury. J Leukoc Biol 64: 528-536.
27. Snider GL, Gelli RR, Goldstein RR, O'Brien JJ, Lucei EC. 1978. Chronic interstitial pulmonary fibrosis produced in hamsters by endotracheal bleomycin. Am Rev Respir Dis 117: 289-297.
28. Strausz J, Muller-Quernheim J, Steppling H, Ferlinz R. 1990. Oxygen radical production by alveolar inflammatory cells in idiopathic pulmonary fibrosis. Am Rev Respir Dis 141: 124-128.
29. Suntres ZE, Shek PN. 1997. Protective effect of liposomal alpha-tocopherol against bleomycin-induced lung injury. Biomed Environ Sci 10: 47-59.
30. Tae J, Han SW, Yoo JY et al. 2003. Anti-inflammatory effect of Lonicera japonica in proteinase-activated receptor 2-mediated paw edema. Clin Chim Acta 330: 165-171.
31. Woessner JB. 1961. The determination of hydroxyproline in tissue and protein samples containing small proportions of this amino acid. Arch Biochem Biophys 93: 440-447.
32. Yu JW, Yoon SS, Yang R. 2001. Iron chlorin e6 scavenges hydroxyl radical and protects human endothelial cells against hydrogen peroxide toxicity. Biol Pharm Bull 24: 1053-1059.
33. Zhang GG, Song SJ, Ren J, Xu SX. 2002. A new compound from Forsythia suspensa (Thunb.) Vahl with antiviral effect on RSV. J Herb Pharmacother 2: 35-40.
34. Zhang K, Phan SH. 1996. Cytokines and pulmonary fibrosis. Biol Signals 5: 232-239.